Top

Published in:

01-04-2021 | Colorectal Cancer

Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors

Authors: Beth A. Glenn, Narissa J. Nonzee, Ann S. Hamilton, Lina Tieu, Annette E. Maxwell, Catherine M. Crespi, L. Cindy Chang, Dennis Deapen, Roshan Bastani

Published in: Journal of Cancer Survivorship | Issue 2/2021

Abstract

Purpose

Cancer survivors diagnosed at an early age remain at risk for cancer recurrence and other chronic diseases. This study assessed engagement in surveillance for recurrence, cancer screening, and other recommended preventive health services among breast and colorectal cancer survivors with early-onset disease (≤ 50 years) who were diagnosed in California.

Methods

Breast and colorectal cancer survivors diagnosed with early-onset cancer between 1999 and 2009 were identified through the California Cancer Registry, the state-based cancer registry, and surveyed. Multivariable regression analyses were used to assess correlates of receipt of cancer surveillance, cancer screening, and other preventive health services.

Results

Of the 497 survivors that were invited to participate in the study, 156 completed the survey for a response rate of 31%. The sample was 50 years of age on average (range 32–69 years) with a mean time since diagnosis of 9 years. The majority of the sample (71%) was a racial/ethnic minority (24% Latino, 15% African American, 29% Asian). Overall, 80% received appropriate surveillance for recurrence, and 72% received recommended screening for early detection of other cancers (breast, cervical, colorectal). Increasing age was associated with lower likelihood of early detection screening (adjusted odds ratio (aOR) 0.28, 95% confidence interval (CI) 0.11–0.69), and higher income was associated with a greater likelihood (aOR 4.89, 95% CI 1.62–14.81). Screening rates were highest for blood pressure (96%), cholesterol (86%), and diabetes (81%), followed by dental visits (64%) and flu vaccination (35%). Greater use of recommended preventive health services was associated with increasing age, female sex, higher education level, and having health insurance.

Conclusions

Although the majority of survivors received appropriate surveillance for recurrence, engagement in other preventive health services varied substantially.

Implications for Cancer Survivors

Efforts are needed to address gaps in the use of recommended cancer screening and preventive health services among cancer survivors, particularly survivors with early-onset disease who may be at increased risk for additional cancers and common chronic conditions over their lifetime.

American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2016-2017. Atlanta: American Cancer Society. 2017.

Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122(6):929–34. https://doi.org/10.1002/cncr.29716.CrossRefPubMedPubMedCentral

Johnson RH, Chien FL, Bleyer A. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA. 2013;309(8):800–5. https://doi.org/10.1001/jama.2013.776.CrossRefPubMed

Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150(1):17–22. https://doi.org/10.1001/jamasurg.2014.1756.

Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J Natl Cancer Inst. 2017;109(8). https://doi.org/10.1093/jnci/djw322.

Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomark Prev. 2007;16(3):566–71. https://doi.org/10.1158/1055-9965.epi-06-0782.CrossRef

Mellemkjær L, Christensen J, Frederiksen K, Pukkala E, Weiderpass E, Bray F et al. Risk of primary non-breast cancer after female breast cancer by age at diagnosis. Cancer Epidemiology and Prevention Biomarkers. 2011:cebp. 0009.2011.

Freedman DM, Curtis R, Travis L, Fraumeni J, Ron E, Ries L et al. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. National Cancer Institute, Bethesda. 2006.

Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, et al. Risk of second cancer among women with breast cancer. Int J Cancer. 2006;118(9):2285–92. https://doi.org/10.1002/ijc.21651.CrossRefPubMed

10.

Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.CrossRef

11.

Singh S, Earle CC, Bae SJ, Fischer HD, Yun L, Austin PC, et al. Incidence of diabetes in colorectal cancer survivors. J Natl Cancer Inst. 2016;108(6):djv402. https://doi.org/10.1093/jnci/djv402.CrossRefPubMed

12.

Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99(5):365–75.CrossRef

13.

Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD. Cardiovascular disease mortality among breast cancer survivors. Epidemiology (Cambridge, Mass). 2016;27(1):6–13. https://doi.org/10.1097/ede.0000000000000394.CrossRef

14.

Trask PC, Rabin C, Rogers ML, Whiteley J, Nash J, Frierson G, et al. Cancer screening practices among cancer survivors. Am J Prev Med. 2005;28(4):351–6. https://doi.org/10.1016/j.amepre.2005.01.005.

15.

Schumacher JR, Witt WP, Palta M, Loconte NK, Heidrich SM, Trentham-Dietz A, et al. Cancer screening of long-term cancer survivors. J Am Board Fam Med. 2012;25(4):460–9. https://doi.org/10.3122/jabfm.2012.04.110118.CrossRefPubMedPubMedCentral

16.

Yabroff KR, Short PF, Machlin S, Dowling E, Rozjabek H, Li C, et al. Access to preventive health care for cancer survivors. Am J Prev Med. 2013;45(3):304–12. https://doi.org/10.1016/j.amepre.2013.04.021.CrossRefPubMedCentral

17.

Uhlig A, Mei J, Baik I, Meyer C, Uhlig J. Screening utilization among cancer survivors: a meta-analysis. J Public Health (Oxf). 2018;40(1):129–37. https://doi.org/10.1093/pubmed/fdx030.CrossRef

18.

Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol. 2008;26(7):1073–9. https://doi.org/10.1200/jco.2007.11.9859.CrossRefPubMed

19.

Kunitake H, Zheng P, Yothers G, Land SR, Fehrenbacher L, Giguere JK, et al. Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01. J Clin Oncol. 2010;28(36):5274–9. https://doi.org/10.1200/jco.2010.30.1903.

20.

Avila JC, Kuo YF, Rodriguez AM, Wong R, Kaul S. Preventive services use among female survivors of adolescent and young adult cancer. J Cancer Surviv. 2017;11(2):167–74. https://doi.org/10.1007/s11764-016-0575-y.CrossRefPubMed

21.

Snyder CF, Earle CC, Herbert RJ, Neville BA, Blackford AL, Frick KD. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med. 2008;23(3):254–9. https://doi.org/10.1007/s11606-007-0497-5.CrossRefPubMedPubMedCentral

22.

Snyder CF, Frick KD, Kantsiper ME, Peairs KS, Herbert RJ, Blackford AL, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27(7):1054–61. https://doi.org/10.1200/jco.2008.18.0950.

23.

Duffy CM, Clark MA, Allsworth JE. Health maintenance and screening in breast cancer survivors in the United States. Cancer Detect Prev. 2006;30(1):52–7. https://doi.org/10.1016/j.cdp.2005.06.012.CrossRefPubMed

24.

Findley PA, Sambamoorthi U. Preventive health services and lifestyle practices in cancer survivors: a population health investigation. J Cancer Surviv. 2009;3(1):43–58. https://doi.org/10.1007/s11764-008-0074-x.CrossRefPubMed

25.

Hudson SV, Hahn KA, Ohman-Strickland P, Cunningham RS, Miller SM, Crabtree BF. Breast, colorectal and prostate cancer screening for cancer survivors and non-cancer patients in community practices. J Gen Intern Med. 2009;24(Suppl 2):S487–90. https://doi.org/10.1007/s11606-009-1036-3.CrossRefPubMed

26.

Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24(1):85–94. https://doi.org/10.1200/jco.2005.02.4174.CrossRefPubMed

27.

Glenn BA, Hamilton AS, Nonzee NJ, Maxwell AE, Crespi CM, Ryerson AB, et al. Obesity, physical activity, and dietary behaviors in an ethnically-diverse sample of cancer survivors with early onset disease. J Psychosoc Oncol. 2018;36:1–19. https://doi.org/10.1080/07347332.2018.1448031.

28.

Maxwell AE, Bastani R, Glenn BA, Taylor VM, Nguyen TT, Stewart SL, et al. Developing theoretically based and culturally appropriate interventions to promote hepatitis B testing in 4 Asian American populations, 2006-2011. Prev Chronic Dis. 2014;11:E72. https://doi.org/10.5888/pcd11.130245.

29.

Bastani R, Glenn BA, Taylor VM, Chen MS Jr, Nguyen TT, Stewart SL, et al. Integrating theory into community interventions to reduce liver cancer disparities: the Health Behavior Framework. Prev Med. 2010;50(1–2):63–7. https://doi.org/10.1016/j.ypmed.2009.08.010.

30.

Bastani R, Gallardo NV, Maxwell AE. Barriers to colorectal cancer screening among ethnically diverse high-and average-risk individuals. J Psychosoc Oncol. 2001;19(3–4):65–84.CrossRef

31.

Bastani R, Glenn BA, Maxwell AE, Jo AM. Hepatitis B among Korean Americans: finding ways to improve testing, vaccination, and better health outcomes. Ethn Dis. 2007;17(2):416–7.PubMed

32.

Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM, et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomark Prev. 2011;20(7):1463–72. https://doi.org/10.1158/1055-9965.epi-11-0267.

33.

Centers for Disease Control and Prevention. National health interview survey. Atlanta, GA: U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. 2010.

34.

Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abraham L. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psychooncology. 2006;15(5):407–21. https://doi.org/10.1002/pon.963.CrossRefPubMedPubMedCentral

35.

Katapodi MC, Northouse LL, Schafenacker AM, Duquette D, Duffy SA, Ronis DL, et al. Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening. BMC Cancer. 2013;13:97. https://doi.org/10.1186/1471-2407-13-97.

36.

Ganz PA. Cognitive functioning after breast cancer treatment. National Institutes of Health (NIH)/National Cancer Institute (NCI) R01 CA109650. 2006.

37.

Burris JL, Jacobsen PB, Loftus LS, Andrykowski MA. Breast cancer recurrence risk reduction beliefs in breast cancer survivors: prevalence and relation to behavior. Psychooncology. 2012;21(4):427–35. https://doi.org/10.1002/pon.1925.CrossRefPubMed

38.

National Comprehensive Cancer Network. NCCN guidelines for colon cancer and breast cancer. 2011. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#detection. Accessed March 14 2011.

39.

American Society of Clinical Oncology. Practice guidelines for breast and colorectal cancer. 2011. http://www.asco.org/portal/site/ascov2. Accessed March 14 2011.

40.

Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(7):674–86. https://doi.org/10.1001/jama.2018.10897.CrossRefPubMed

41.

Siu AL. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2016;164(4):279–96. https://doi.org/10.7326/m15-2886.CrossRefPubMed

42.

Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garcia FAR, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315(23):2564–75. https://doi.org/10.1001/jama.2016.5989.CrossRefPubMed

43.

Siu AL. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778–86. https://doi.org/10.7326/m15-2223.CrossRefPubMed

44.

Siu AL. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(11):861–8. https://doi.org/10.7326/m15-2345.CrossRefPubMed

45.

Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States, 2018–19 Influenza Season. MMWR Recomm Rep. 2018;67(3):1–20. https://doi.org/10.15585/mmwr.rr6703a1.CrossRefPubMedPubMedCentral

46.

Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garcia FA, et al. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. Jama. 2016;316(19):1997–2007. https://doi.org/10.1001/jama.2016.15450.CrossRefPubMed

47.

American Dental Association Statement on Regular Dental Visits. Chicago: American Dental Association. 2013.

48.

Glenn BA, Hamilton AS, Nonzee NJ, Maxwell AE, Crespi CM, Ryerson AB, et al. Obesity, physical activity, and dietary behaviors in an ethnically-diverse sample of cancer survivors with early onset disease. J Psychosoc Oncol. 2018;36(4):418–36. https://doi.org/10.1080/07347332.2018.1448031.

49.

Ruddy KJ, Sangaralingham L, Freedman RA, Mougalian S, Neuman H, Greenberg C, et al. Adherence to guidelines for breast surveillance in breast cancer survivors. J Natl Compr Canc Netw. 2018;16(5):526–34. https://doi.org/10.6004/jnccn.2018.7001.CrossRefPubMed

50.

Carpentier MY, Vernon SW, Bartholomew LK, Murphy CC, Bluethmann SM. Receipt of recommended surveillance among colorectal cancer survivors: a systematic review. J Cancer Surviv. 2013;7(3):464–83. https://doi.org/10.1007/s11764-013-0290-x.CrossRefPubMedPubMedCentral

51.

Advani PS, Ying J, Theriault R, Melhem-Bertrand A, Moulder S, Bedrosian I, et al. Ethnic disparities in adherence to breast cancer survivorship surveillance care. Cancer. 2014;120(6):894–900. https://doi.org/10.1002/cncr.28490.

52.

Bellizzi KM, Rowland JH, Jeffery DD, McNeel T. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23(34):8884–93.CrossRef

53.

Homan SG, Kayani N, Yun S. Risk factors, preventive practices, and health care among breast cancer survivors, United States, 2010. Prev Chronic Dis. 2016;13:E09. https://doi.org/10.5888/pcd13.150377.CrossRefPubMedPubMedCentral

54.

Lai JH, Park G, Gerson LB. Association between breast cancer and the risk of colorectal cancer. Gastrointest Endosc. 2017;86(3):429–41.e1. https://doi.org/10.1016/j.gie.2017.04.008.CrossRefPubMed

55.

Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med. 2012;43(1):97–118. https://doi.org/10.1016/j.amepre.2012.04.009.

56.

Jansana A, Posso M, Guerrero I, Prados-Torres A, Del Cura MI, Castells X, et al. Health care services use among long-term breast cancer survivors: a systematic review. J Cancer Surviv. 2019;13(3):477–93. https://doi.org/10.1007/s11764-019-00755-z.CrossRefPubMed

57.

Gupta S, Cole AP, Marchese M, Wang Y, Speed JM, Fletcher SA, et al. Use of preventive health services among cancer survivors in the U.S. Am J Prev Med. 2018;55(6):830–8. https://doi.org/10.1016/j.amepre.2018.07.021.

58.

Guy GP Jr, Yabroff KR, Ekwueme DU, Virgo KS, Han X, Banegas MP, et al. Healthcare expenditure burden among non-elderly cancer survivors, 2008-2012. Am J Prev Med. 2015;49(6 Suppl 5):S489–97. https://doi.org/10.1016/j.amepre.2015.09.002.

59.

Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101(8):1712–9. https://doi.org/10.1002/cncr.20560.CrossRefPubMed

60.

Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504. https://doi.org/10.1002/cncr.25209.CrossRefPubMedPubMedCentral

61.

de Moor JS, Virgo KS, Li C, Chawla N, Han X, Blanch-Hartigan D, et al. Access to cancer care and general medical care services among cancer survivors in the United States: an analysis of 2011 medical expenditure panel survey data. Public Health Rep (Washington, DC : 1974). 2016;131(6):783–90. https://doi.org/10.1177/0033354916675852.CrossRef

62.

McPhee SJ, Nguyen TT, Shema SJ, Nguyen B, Somkin C, Vo P, et al. Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Prev Med. 2002;35(5):463–73.CrossRef

63.

Paskett ED, Tatum CM, Mack DW, Hoen H, Case LD, Velez R. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Prev Biomarkers. 1996;5(9):721–6.

64.

Champion VL, Menon U, McQuillen DH, Scott C. Validity of self-reported mammography in low-income African-American women. Am J Prev Med. 1998;14(2):111–7.CrossRef

65.

Powe BD, Cooper DL. Self-reported cancer screening rates versus medical record documentation: incongruence, specificity, and sensitivity for African American women. Oncol Nurs Forum. 2008;35(2):199–204. https://doi.org/10.1188/08.Onf.199-204.CrossRefPubMed

66.

Suarez L, Pulley L. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women. J Natl Cancer Inst Monogr. 1995;18:41–7.

67.

California Health Interview Survey. CHIS 2015 methodology report series: report 4 response rates short report. UCLA Center for Health Policy Research: Los Angeles. 2016.

68.

Behavioral Risk Factor Surveillance System. 2018 Summary data quality report. Atlanta: Centers for Disease Control and Prevention. 2019.

69.

Maitland A, Lin A, Cantor D, Jones M, Moser RP, Hesse BW, et al. A nonresponse bias analysis of the Health Information National Trends Survey (HINTS). J Health Commun. 2017;22(7):545–53. https://doi.org/10.1080/10810730.2017.1324539.

70.

Blanch-Hartigan D, Chawla N, Moser RP, Finney Rutten LJ, Hesse BW, Arora NK. Trends in cancer survivors’ experience of patient-centered communication: results from the Health Information National Trends Survey (HINTS). J Cancer Surviv. 2016;10(6):1067–77. https://doi.org/10.1007/s11764-016-0550-7.CrossRefPubMed

71.

Boehmer U, Miao X, Ozonoff A. Health behaviors of cancer survivors of different sexual orientations. Cancer Causes Control. 2012;23(9):1489–96. https://doi.org/10.1007/s10552-012-0023-x.CrossRefPubMed

72.

Breslau ES, Jeffery DD, Davis WW, Moser RP, McNeel TS, Hawley S. Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey. J Cancer Surviv. 2010;4(1):1–14. https://doi.org/10.1007/s11764-009-0102-5.CrossRefPubMed

73.

Byrd DA, Agurs-Collins T, Berrigan D, Lee R, Thompson FE. Racial and ethnic differences in dietary intake, physical activity, and body mass index (BMI) among cancer survivors: 2005 and 2010 National Health Interview Surveys (NHIS). J Racial Ethn Health Disparities. 2017;4(6):1138–46. https://doi.org/10.1007/s40615-016-0319-8.CrossRefPubMed

74.

Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64. https://doi.org/10.3322/caac.21601.

Title: Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors
Authors: Beth A. Glenn
Narissa J. Nonzee
Ann S. Hamilton
Lina Tieu
Annette E. Maxwell
Catherine M. Crespi
L. Cindy Chang
Dennis Deapen
Roshan Bastani
Publication date: 01-04-2021
Publisher: Springer US
Keywords: Colorectal Cancer
Colorectal Cancer
Published in: Journal of Cancer Survivorship / Issue 2/2021
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-020-00925-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 2/2021

Associations between shared care and patient experiences among older cancer survivors

Identifying and exploring the self-management strategies used by childhood cancer survivors

Acceptability of online exercise-based interventions after breast cancer surgery: systematic review and narrative synthesis

The experiences and needs of couples affected by prostate cancer aged 65 and under: a qualitative study

Healthcare fragmentation and cardiovascular risk control among older cancer survivors in the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study

Effects of a wearable technology-based physical activity intervention on sleep quality in breast cancer survivors: the ACTIVATE Trial

Keynote webinar | Spotlight on antibody–drug conjugates in cancer